Product Description: Balugrastim (CG 10639) is a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF) obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating factor. Balugrastim can be used for the research of breast cancer[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Ghidini M, et al. New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim. Ther Clin Risk Manag. 2016 Jun 24;12:1009-15.